Literature DB >> 26774561

Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction.

Tomo Yoshizumi1, Yang Zhu2, Hongbin Jiang1, Antonio D'Amore1, Hirokazu Sakaguchi1, Jason Tchao3, Kimimasa Tobita4, William R Wagner5.   

Abstract

Intramyocardial injection of various injectable hydrogel materials has shown benefit in positively impacting the course of left ventricular (LV) remodeling after myocardial infarction (MI). However, since LV remodeling is a complex, time dependent process, the most efficacious time of hydrogel injection is not clear. In this study, we injected a relatively stiff, thermoresponsive and bioabsorbable hydrogel in rat hearts at 3 different time points - immediately after MI (IM), 3 d post-MI (3D), and 2 w post-MI (2W), corresponding to the beginnings of the necrotic, fibrotic and chronic remodeling phases. The employed left anterior descending coronary artery ligation model showed expected infarction responses including functional loss, inflammation and fibrosis with distinct time dependent patterns. Changes in LV geometry and contractile function were followed by longitudinal echocardiography for 10 w post-MI. While all injection times positively affected LV function and wall thickness, the 3D group gave better functional outcomes than the other injection times and also exhibited more local vascularization and less inflammatory markers than the earlier injection time. The results indicate an important role for injection timing in the increasingly explored concept of post-MI biomaterial injection therapy and suggest that for hydrogels with mechanical support as primary function, injection at the beginning of the fibrotic phase may provide improved outcomes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac tissue engineering; Hydrogel; Injectable materials; Intervention timing; Myocardial infarction

Mesh:

Substances:

Year:  2015        PMID: 26774561      PMCID: PMC4754148          DOI: 10.1016/j.biomaterials.2015.12.002

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  44 in total

1.  Theoretical impact of the injection of material into the myocardium: a finite element model simulation.

Authors:  Samuel T Wall; Joseph C Walker; Kevin E Healy; Mark B Ratcliffe; Julius M Guccione
Journal:  Circulation       Date:  2006-11-27       Impact factor: 29.690

2.  Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel.

Authors:  So Jeong Yoon; Yong Hu Fang; Choon Hak Lim; Bum Shik Kim; Ho Sung Son; Yongdoo Park; Kyung Sun
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-10       Impact factor: 3.368

3.  Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair.

Authors:  Masaho Okada; Thomas R Payne; Hideki Oshima; Nobuo Momoi; Kimimasa Tobita; Johnny Huard
Journal:  Biomaterials       Date:  2010-07-31       Impact factor: 12.479

4.  Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.

Authors:  Sandra B Haudek; Jizhong Cheng; Jie Du; Yanlin Wang; Jesus Hermosillo-Rodriguez; JoAnn Trial; George E Taffet; Mark L Entman
Journal:  J Mol Cell Cardiol       Date:  2010-05-19       Impact factor: 5.000

5.  Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability.

Authors:  Zuwei Ma; Devin M Nelson; Yi Hong; William R Wagner
Journal:  Biomacromolecules       Date:  2010-07-12       Impact factor: 6.988

Review 6.  Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.

Authors:  Devin M Nelson; Zuwei Ma; Kazuro L Fujimoto; Ryotaro Hashizume; William R Wagner
Journal:  Acta Biomater       Date:  2010-07-07       Impact factor: 8.947

7.  Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs.

Authors:  Yi-Dong Lin; Ming-Long Yeh; Yu-Jen Yang; Da-Ching Tsai; Ting-Yu Chu; Ya-Yun Shih; Min-Yao Chang; Yen-Wen Liu; Alan C L Tang; Tsai-Yun Chen; Chwan-Yau Luo; Kung-Chao Chang; Jyh-Hong Chen; Hua-Lin Wu; Tin-Kan Hung; Patrick C H Hsieh
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

8.  Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel.

Authors:  Haibin Wang; Xuelian Zhang; Yanmin Li; Yitong Ma; Ye Zhang; Zhiqiang Liu; Jin Zhou; Qiuxia Lin; Yanmeng Wang; Cuimi Duan; Changyong Wang
Journal:  J Heart Lung Transplant       Date:  2010-05-13       Impact factor: 10.247

9.  An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction.

Authors:  Kazuro L Fujimoto; Kimimasa Tobita; W David Merryman; Jianjun Guan; Nobuo Momoi; Donna B Stolz; Michael S Sacks; Bradley B Keller; William R Wagner
Journal:  J Am Coll Cardiol       Date:  2007-05-25       Impact factor: 24.094

10.  Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium.

Authors:  Kazuro L Fujimoto; Zuwei Ma; Devin M Nelson; Ryotaro Hashizume; Jianjun Guan; Kimimasa Tobita; William R Wagner
Journal:  Biomaterials       Date:  2009-05-31       Impact factor: 12.479

View more
  18 in total

1.  Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.

Authors:  Zhaobo Fan; Minghuan Fu; Zhaobin Xu; Bo Zhang; Zhihong Li; Haichang Li; Xinyu Zhou; Xuanyou Liu; Yunyan Duan; Pei-Hui Lin; Pu Duann; Xiaoyun Xie; Jianjie Ma; Zhenguo Liu; Jianjun Guan
Journal:  Biomacromolecules       Date:  2017-08-07       Impact factor: 6.988

2.  Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair.

Authors:  Jeffrey J D Henry; Lawrence Delrosario; Jun Fang; Sze Yue Wong; Qizhi Fang; Richard Sievers; Surya Kotha; Aijun Wang; Diana Farmer; Praneeth Janaswamy; Randall J Lee; Song Li
Journal:  Adv Healthc Mater       Date:  2019-11-28       Impact factor: 9.933

3.  Injectable Drug-Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction.

Authors:  Jun Fang; Jaekyung Koh; Qizhi Fang; Huiliang Qiu; Maani M Archang; Mohammad Mahdi Hasani-Sadrabadi; Hiromi Miwa; Xintong Zhong; Richard Sievers; Dong-Wei Gao; Randall Lee; Dino Di Carlo; Song Li
Journal:  Adv Funct Mater       Date:  2020-09-06       Impact factor: 18.808

4.  Biodegradable nanofibrous temperature-responsive gelling microspheres for heart regeneration.

Authors:  Chao Zhao; Shuo Tian; Qihai Liu; Kemao Xiu; Ienglam Lei; Zhong Wang; Peter X Ma
Journal:  Adv Funct Mater       Date:  2020-03-20       Impact factor: 18.808

Review 5.  Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.

Authors:  Yang Zhu; Yasumoto Matsumura; William R Wagner
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

6.  Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling.

Authors:  Christopher B Rodell; Madonna E Lee; Hua Wang; Satoshi Takebayashi; Tetsushi Takayama; Tomonori Kawamura; Jeffrey S Arkles; Neville N Dusaj; Shauna M Dorsey; Walter R T Witschey; James J Pilla; Joseph H Gorman; Jonathan F Wenk; Jason A Burdick; Robert C Gorman
Journal:  Circ Cardiovasc Interv       Date:  2016-10       Impact factor: 6.546

7.  Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

Authors:  Yang Zhu; Sato Hideyoshi; Hongbin Jiang; Yasumoto Matsumura; Jenna L Dziki; Samuel T LoPresti; Luai Huleihel; Gabriela N F Faria; Leah C Fuhrman; Ricardo Lodono; Stephen F Badylak; William R Wagner
Journal:  Acta Biomater       Date:  2018-04-10       Impact factor: 8.947

8.  Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.

Authors:  Zhaobo Fan; Zhaobin Xu; Hong Niu; Yang Sui; Haichang Li; Jianjie Ma; Jianjun Guan
Journal:  J Control Release       Date:  2019-09-12       Impact factor: 9.776

9.  Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process?

Authors:  Lindemberg M Silveira-Filho; Garrett N Coyan; Arianna Adamo; Samuel K Luketich; Giorgio Menallo; Antonio D'Amore; William R Wagner
Journal:  JACC Basic Transl Sci       Date:  2021-03-24

Review 10.  Antifibrotic therapies to control cardiac fibrosis.

Authors:  Zhaobo Fan; Jianjun Guan
Journal:  Biomater Res       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.